Concordance of pharmacogenetic markers in germline and colorectal tumor DNA

Author： Marsh Sharon Mallon Mary Ann Goodfellow Paul McLeod Howard L

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.6, Iss.8, 2005-12, pp. : 873-877

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients

By Cortejoso Lucía López-Fernández Luis A

Pharmacogenomics, Vol. 13, Iss. 10, 2012-07 ,pp. : 1173-1191

Future Medicine

Access to resources Recommend Favorite

Concordance of genotype for polymorphisms in DNA isolated from peripheral blood and colorectal cancer tumor samples

By van Huis-Tanja Lieke Kweekel Dinemarie Gelderblom Hans Koopman Miriam Punt Kees Guchelaar Henk-Jan van der Straaten Tahar

Pharmacogenomics, Vol. 14, Iss. 16, 2013-12 ,pp. : 2005-2012

Future Medicine

Access to resources Recommend Favorite

Cancer Pharmacogenomics: Germline DNA, Tumor DNA, or Both?

Current Pharmacogenomics, Vol. 5, Iss. 2, 2007-06 ,pp. : 87-101

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic aspects in treatment of colorectal cancer – an update

By Stoehlmacher Jan Goekkurt Eray Lenz Heinz-Josef

Pharmacogenomics, Vol. 4, Iss. 6, 2003-11 ,pp. : 767-777

Future Medicine

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacogenetic Predictive Markers of Irinotecan Activity and Toxicity

Current Drug Metabolism, Vol. 12, Iss. 10, 2011-12 ,pp. : 932-943

Bentham Science Publishers

Access to resources Recommend Favorite